The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes
Open accessAbstract
Aims Chemical inhibitors of cytochrome P450 (CYP) are a useful tool in defining the role of individual CYPs involved in drug metabolism. The aim of the present study was to evaluate the selectivity and rank the order of potency of a range of isoform‐selective CYP inhibitors and to compare directly the effects of these inhibitors in human and rat hepatic microsomes. Methods Four chemical inhibitors of human cytochrome P450 isoforms, furafylline (CYP1A2), sulphaphenazole (CYP2C9), diethyldithiocarbamate (CYP2E1), and ketoconazole (CYP3A4) were screened for their inhibitory specificity towards CYP‐mediated reactions in both human and rat liver microsomal preparations. Phenacetin O‐deethylation, tolbutamide 4‐hydroxylation, chlorzoxazone 6‐hydroxylation and testosterone 6β‐hydroxylation were monitored for enzyme activity. Results Furafylline was a potent, selective inhibitor of phenacetin O‐deethylation (CYP1A2‐mediated) in human liver microsomes (IC50=0.48 μm ), but inhibited both phenacetin O‐deethylation and tolbutamide 4‐hydroxylation (CYP2C9‐mediated) at equimolar concentrations in rat liver microsomes (IC50=20.8 and 24.0 μm respectively). Sulphaphenazole demonstrated selective inhibition of tolbutamide hydroxylation in human liver microsomes but failed to inhibit this reaction in rat liver microsomes. DDC demonstrated a low level of selectivity as an inhibitory probe for chlorzoxazone 6‐hydroxylation (CYP2E1‐mediated). DDC also inhibited testosterone 6β‐hydroxylation (CYP3A‐mediated) in man and rat, and tolbutamide 4‐hydroxylase activity in rat. Ketoconazole was a very potent, selective inhibitor of CYP3A4 activity in human liver (IC50=0.04 μm ). Although inhibiting CYP3A in rat liver it also inhibited all other reactions at concentrations ≤5 μm. Conclusions It is evident that CYP inhibitors do not exhibit the same selectivity in human and rat liver microsomes. This is due to differential selectivity of the inhibitors and/or differences in the CYP isoform responsible for metabolism in the different species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects
Guengerich, F. P., Kim, D. H., & Iwasaki, M. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00020a008 · Cited by 1,169
Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., & Kaminsky, L. S. (1982) · Biochemistry · doi:10.1021/bi00266a045 · Cited by 1,012
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1
Peter, R., Boecker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., & Yang, C. S. (1990) · Chemical Research in Toxicology · doi:10.1021/tx00018a012 · Cited by 528
Waxman, D. J., Attisano, C., Guengerich, F. P., & Lapenson, D. P. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90655-8 · Cited by 414
Wood, A. W., Ryan, D. E., Thomas, P. E., & Levin, W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32132-x · Cited by 338
Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450
Sonderfan, A. J., Arlotto, M. P., Dutton, D. R., McMillen, S. K., & Parkinson, A. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90291-8 · Cited by 326
Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s
Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., & Korzekwa, K. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90602-f · Cited by 324
Cited by
Effects of the Antifungal Agents on Oxidative Drug Metabolism: Clinical Relevance
Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038020-00002 · Cited by 508
VALIDATED ASSAYS FOR HUMAN CYTOCHROME P450 ACTIVITIES
Walsky, R. L., & Obach, R. S. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.647 · Cited by 507
Kot, M., & Daniel, W. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.025 · Cited by 388
Bogaards, J. J. P., Bertrand, M., Jackson, P., Oudshoorn, M. J., Weaver, R. J., Van Bladeren, P. J., & Walther, B. (2000) · Xenobiotica · doi:10.1080/00498250010021684 · Cited by 368
McDonald, M. G., Rieder, M. J., Nakano, M., Hsia, C. K., & Rettie, A. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054833 · Cited by 320
Metadata
- Authors
- Eagling, V. A., Tjia, J. F., & Back, D. J.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1998-02
- Volume
- 45
- Issue
- 2
- Pages
- 107-114
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1746765074
- Cited by
- 333
- References
- 30
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. https://app.cochat.ai/papers/10.1046/j.1365-2125.1998.00679.x
- The paper
- Eagling, V. A., Tjia, J. F., & Back, D. J. (1998). Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1998.00679.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
